Kimberly Ray has joined Eisai as senior manager, pharmacoepidemiology and risk management in medical services. Prior to joining Eisai, Ray was employed as associate manager, global pharmacovigilance and epidemiology at Bristol-Myers Squibb in Hopewell, NJ. Additionally, Barbara Lewis, PhD, MHA has joined Eisai Corporation of North America as director, global health economics and outcomes research (HEOR). Lewis joins Eisai from AstraZeneca where she was a field-based HEOR director primarily working with managed care organizations and large medical groups in the Northeast. She also worked on headquarter-based research studies in oncology and CNS
NPS Pharmaceuticals announced the appointment of Alan Harris, MD, PhD, as SVP and chief medical officer (CMO). Before joining NPS, Harris was CMO of Manhattan Pharmaceuticals, therapeutic head of worldwide medical endocrine care at Pfizer and VP of global health research and outcomes at Schering-Plough, where he held a variety of senior medical affairs positions.
The Philadelphia office of Avenue A | Razorfish, has added three new staff members. Don Bruns has joined as user experience lead, Jedd Davis has joined as strategy director and Ron Wessels has joined as associate creative director.